Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:11 - 18
Updated:11/23/2013
Start Date:June 2009
End Date:December 2012
Contact:Nicholas Raviele, BS
Email:nicholas.raviele@emory.edu
Phone:4047273189

Use our guide to learn which trials are right for you!


Primary Objectives:

1. To determine whether a 4 week reduction in dietary fructose intake improves hepatic
steatosis in overweight children who have a baseline high fructose consumption and
hepatic steatosis.

2. To determine if a 4 week reduction of dietary fructose improves fasting plasma
triglycerides, free fatty acids, VLDL, insulin and glucose as well as post-prandial
levels in response to a high fructose meal.

3. To determine if a 4 week reduction of dietary fructose improves markers of oxidative
stress.

Study Design: A blinded randomized study comparing glucose beverages to isocaloric fructose
beverages administered over 4 weeks.


Planned Sample Size: Phase 1) 96 subjects Phase 2) 40 subjects

Patient Population: Overweight Hispanic children with NAFLD age 11 to 18 years who are
stable and not taking any chronic medication with no recent acute illnesses.

Definitions:

- BMI >95th %tile for age and gender

- Self-identified as Hispanic/Latino

- Baseline hepatic fat fraction > 10% (Have nonalcoholic fatty liver disease)

- Sweetened beverage intake of at least 24 ounces/day

Inclusion Criteria:

- BMI > 85th %tile

- Self identified as Hispanic

- Age 11-18 years

- Baseline hepatic fat fraction >8%

- Self reported sugar beverage intake of at least 24 oz (equivalent to 3 sugar
sweetened drinks per day).

Exclusion Criteria:

- Currently attempting weight gain or weight loss

- Cirrhosis visible on baseline MRI

- Renal insufficiency found on screening labs (creatinine > 2)

- Recent acute illness within past 4 weeks (defined by fever > 100.4ºF)

- Pregnancy

- Chronic illness requiring medication including diabetes

- Fasting glucose >120 on screening labs
We found this trial at
1
site
Atlanta, Georgia 30322
?
mi
from
Atlanta, GA
Click here to add this to my saved trials